Lung cancer (LC) and chronic obstructive pulmonary disease (COPD) are among the
leading causes of mortality worldwide. Cigarette smoking is among the main aetiologic …

Liposomes, as a colloidal drug delivery system dating back to the 1960s, remain a focal
point of extensive research and stand as a highly efficient drug delivery method. The …

Extracellular vesicles (EVs) are nanoparticles released from various cell types that have
emerged as powerful new therapeutic option for a variety of diseases. EVs are involved in …

Field-flow fractionation (FFF) with its several variants, has developed into a mature
methodology. The scope of the FFF investigations has expanded, covering both a wide …

Introduction Drug delivery across the blood-brain barrier (BBB) is challenging and therefore
severely restricts neurodegenerative diseases therapy such as Alzheimer's disease (AD) …

Ocular retinoblastoma malignancies, which develop into metastatic phenotypes, result in
poor prognosis and survival for infant and child patients. To improve the prognosis of …

Despite advances in drug delivery technologies, treating acute respiratory distress
syndrome (ARDS) is challenging due to pathophysiological barriers such as lung injury …

Pulmonary drug delivery has the advantages of being rapid, efficient, and well-targeted, with
few systemic side effects. In addition, it is non-invasive and has good patient compliance …

Chemotherapy drugs like doxorubicin (Dox) are widely used in middle-income countries
around the world to treat various types of cancers, including breast cancer. Although they …

Extracellular vesicles (EVs)/exosomes are nanosized membrane-bound structures that are
released by virtually all cells. EVs have attracted great attention in the scientific community …